Wealth Growth Daily

Health

J&J may eye deals that boost eye care, surgical robots businesses – CEO

BY Reuters  • January 9, 2023January 9, 2023
By Leroy Leo and Aditya Samal (Reuters) – Johnson & Johnson will look for opportunities to merge with or acquire firms that add value to its focus areas of eye care, surgical robots, orthope[...]
Read more
Business Health Updated US

Teva says opioids settlement to move forward in U.S

BY Reuters  • January 9, 2023January 9, 2023
(Reuters) -Israeli drugmaker Teva Pharmaceutical Industries Ltd said there was sufficient participation from U.S. states and local authorities to move forward with its nationwide settlement agreement[...]
Read more
Business Health Top News Updated

Novavax’s longtime CEO Stanley Erck to retire

BY Reuters  • January 9, 2023January 9, 2023
(Reuters) – Novavax Inc said on Monday its longtime chief executive officer, Stanley Erck, would retire and be succeeded by industry veteran John Jacobs, at a time when the COVID-19 vaccine make[...]
Read more
Business Health US

French drug company Servier launches Mediator appeal

BY Reuters  • January 9, 2023January 9, 2023
PARIS (Reuters) – French drugmaker Servier on Monday launched its appeal against manslaughter and deception convictions handed down by a Paris court in 2021 in connection with weight-loss pill M[...]
Read more
Business Economy Europe Health Politics

Eisai, Biogen’s Alzheimer’s drug price should not dent demand – analysts

BY Reuters  • January 9, 2023January 9, 2023
(Reuters) – The $26,500-per-year price tag for Eisai Co Ltd and Biogen Inc’s newly approved Alzheimer’s disease drug is slightly above expectations, but should not dent demand for th[...]
Read more
Asia Business Health US

AstraZeneca boosts heart, kidney business with $1.8 billion CinCor deal

BY Reuters  • January 9, 2023January 9, 2023
By Natalie Grover (Reuters) -AstraZeneca said on Monday it had struck a deal to buy U.S.-based drug developer CinCor Pharma Inc for up to $1.8 billion to increase its stock of heart and kidney drugs.[...]
Read more
Business Economy Europe Health UK Updated US

Private equity acquires a taste for drug development

BY Reuters  • January 9, 2023January 9, 2023
By David Carnevali (Reuters) – Private equity firms that deemed drug development too risky for their liking in the past are increasingly investing in the sector, raising dedicated funds and comi[...]
Read more
Asia Australia Business Economy Europe Health Top News UK US

Qiagen acquires DNA-biometrics firm Verogen in $150 million deal

BY Reuters  • January 9, 2023January 9, 2023
(Reuters) – Life sciences firm Qiagen said on Monday it has acquired DNA-biometrics firm Verogen in a $150-million cash deal, strengthening its forensics portfolio. The deal builds on the compan[...]
Read more
Business Europe Health

Airlines lift China international flight capacity as border opens – Cirium data

BY Reuters  • January 9, 2023January 9, 2023
By Jamie Freed and Sophie Yu SYDNEY/BEIJING (Reuters) – Airlines have boosted January international seat capacity to and from China by 9.5% over the last week as they ramp up flights after its b[...]
Read more
Asia Business Health Updated
« Previous 1 … 41 42 43 44 45 … 52 Next »
Wealth Growth Daily
PRIVACY POLICY

Copyright © 2026 Wealth Growth Daily. All Rights Reserved.

HIGH RISK WARNING

Trading foreign exchange, stocks, options, or futures on margin carries a high level of risk, and may not be suitable for all investors. Before deciding to trade, you should carefully consider your objectives, financial situation, needs and level of experience. Wealth Growth Daily provides general advice that does not take into account your objectives, financial situation or needs. The content of this website must not be construed as personal advice. The possibility exists that you could sustain a loss in excess of your deposited funds and therefore, you should not speculate with capital that you cannot afford to lose. You should be aware of all the risks associated with trading on margin. You should seek advice from an independent financial advisor. Past performance is not necessarily indicative of future success.

101 Marketside Ave. Suite 404 PMB 318 Ponte Vedra, FL 32081 | (321) 325-1551